Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 2005

Conditions
HIV Infections
Interventions
DRUG

indinavir sulfate

DRUG

ritonavir

Trial Locations (12)

10029

Metropolitan Hosp. Ctr., New York

10032

Columbia IMPAACT CRS, New York

10037

Harlem Hosp. Ctr. NY NICHD CRS, New York

13210

SUNY Upstate Med. Univ., Dept. of Peds., Syracuse

20060

Howard Univ. Washington DC NICHD CRS, Washington D.C.

23219

VCU Health Systems, Dept. of Peds, Richmond

32209

Univ. of Florida Jacksonville NICHD CRS, Jacksonville

32610

Univ. of Florida College of Medicine-Dept of Peds, Div. of Immunology, Infectious Diseases & Allergy, Gainesville

77030

Texas Children's Hosp. CRS, Houston

381052794

St. Jude/UTHSC CRS, Memphis

606143394

Chicago Children's CRS, Chicago

009367344

San Juan City Hosp. PR NICHD CRS, San Juan

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00012519 - Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment | Biotech Hunter | Biotech Hunter